Orencia vs. TNF Antagonists - What's The Difference?

Orencia (abatacept) was the first T-cell co-stimulation modulator approved for rheumatoid arthritis back in December 2005. What is its mechanism of action? How is Orencia (abatacept) different from other biologics such as:

• Enbrel (etanercept)
• Remicade (infliximab)
• Humira (adalimumab)
• Kineret (anakinra)

Who will be candidates to successfully use Orencia? Could it be prescribed to patients before they have tried or failed other biologics (Enbrel, Remicade, Humira, Anakinra)? Dr. Scott J. Zashin answers our questions about Orencia.

• More About Orencia (Abatacept)
• Orencia (Abatacept) Approved For Rheumatoid Arthritis
• Drugs A-Z - Orencia (Abatacept)